Oncode Scientific Sdn Bhd
201501029484 (1154805-X)
Leading the Precision Medicine Revolution in Asia
Since 2015, Oncode Scientific Sdn Bhd has emerged as a trailblazer in the realm of precision medicine, setting new benchmarks in cancer molecular diagnostics. Our multidisciplinary team, comprising top-tier experts from molecular science and clinical practice, brings together decades of experience in medical diagnostics and research. At our cutting-edge facilities in Malaysia, we spearhead one of Asiaโs most pioneering precision medicine initiatives, specializing in both solid tumors and hematologic cancers. Our relentless pursuit of innovation drives us to constantly challenge the status quo, exceeding clinical and diagnostic standards to deliver groundbreaking medical solutions. Oncode is dedicated to transforming healthcareโadvancing disease prevention, early detection, and targeted intervention. With a commitment to excellence, we provide world-class molecular diagnostic services that are both accessible and revolutionary, empowering the global community to embrace the full potential of precision medicine.
27/09/2025
Oncode is at the ๐ฏ๐ฒ๐๐ต ๐๐ป๐ป๐๐ฎ๐น ๐ฆ๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐ ๐ผ๐ณ ๐๐ต๐ฒ ๐ ๐ฎ๐น๐ฎ๐๐๐ถ๐ฎ๐ป ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น ๐ฆ๐ผ๐ฐ๐ถ๐ฒ๐๐ (๐๐ฆ๐๐ข๐ ๐ข๐ฆ ๐ฎ๐ฌ๐ฎ๐ฑ) this weekend, championing innovation and quality in precision oncology.
๐ 26โ28 September 2025
๐ Persada Johor International Convention Centre, Malaysia
1๏ธโฃ Actionable Mutation Landscape in Malaysiaโs Top Three Cancers: Insights from Routine NGS Testing with EQA-Assured Accuracy
๐ Selected as a ๐ง๐ผ๐ฝ ๐ญ๐ฌ ๐ฃ๐ผ๐๐๐ฒ๐ฟ ๐๐ถ๐ป๐ฎ๐น๐ถ๐๐. Join us for the live poster presentation, taking place at the Foyer.
๐ 27 Sept | ๐ 3:15โ4:15PM | ๐ Foyer outside Tanjung Puteri Convention Halls (Level 3)
2๏ธโฃ Bridging Gaps in Cancer Diagnostics: Implementation of a 500-Gene Comprehensive Genomic Profiling Panel to Support Precision Oncology in Malaysia
-
๐ค ๐ฉ๐ถ๐๐ถ๐ ๐จ๐ ๐ฎ๐ ๐๐ผ๐ผ๐๐ต ๐๐ฎ๐ฌ
Discover how weโre redefining solid tumour diagnostics and care with advanced tissue- and liquid-based molecular solutions.
โจ Together, letโs turn genomic insights into hope โ advancing oncology with trusted molecular diagnostics.
22/09/2025
On 27th August 2025, Oncode conducted a CME session with the ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐๐ฎ๐ฒ๐บ๐ฎ๐๐ผ๐น๐ผ๐ด๐ ๐๐ฒ๐ฎ๐บ ๐ฎ๐ ๐จ๐ป๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐ ๐ ๐ฎ๐น๐ฎ๐๐ฎ ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ป๐๐ฟ๐ฒ (๐จ๐ ๐ ๐) on โ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐๐ฝ๐ฝ๐ฟ๐ผ๐ฎ๐ฐ๐ต๐ฒ๐ ๐ถ๐ป ๐๐๐ง๐ฏ-๐ ๐๐๐ฎ๐๐ฒ๐ฑ ๐ฎ๐ป๐ฑ ๐ฅ๐ฒ๐น๐ฎ๐ฝ๐๐ฒ๐ฑ/๐ฅ๐ฒ๐ณ๐ฟ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ ๐.โ
The session compared ๐๐๐ง๐ฏ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ฒ๐๐๐ถ๐ป๐ด ๐๐ฒ๐ฐ๐ต๐ป๐ถ๐พ๐๐ฒ๐, highlighting their ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ฒ๐น๐ฒ๐๐ฎ๐ป๐ฐ๐ฒ, ๐น๐ถ๐บ๐ถ๐๐ฎ๐๐ถ๐ผ๐ป๐, and the critical need for ๐ณ๐ฎ๐๐ ๐๐๐ฟ๐ป๐ฎ๐ฟ๐ผ๐๐ป๐ฑ ๐๐ถ๐บ๐ฒ in guiding treatment. ๐๐ฎ๐๐ฒ ๐๐๐๐ฑ๐ถ๐ฒ๐ demonstrated the value of ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐บ๐ผ๐ป๐ถ๐๐ผ๐ฟ๐ถ๐ป๐ด in AML management.
We also introduced the ๐ข๐ป๐ฐ๐ผ๐ฑ๐ฒโ๐๐๐๐ฒ๐น๐น๐ฎ๐ ๐๐๐ง๐ฏ๐บ ๐ง๐ฒ๐๐๐ถ๐ป๐ด ๐๐ผ๐ฝ๐ฎ๐ ๐ฃ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ๐บ๐ฒ, offering ๐๐๐ฏ๐๐ถ๐ฑ๐ถ๐๐ฒ๐ฑ ๐๐๐ง๐ฏ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป ๐๐ฒ๐๐๐ถ๐ป๐ด for eligible UMMC patients.
Thank you to the UMMC team for your active participation in advancing precision haematology.
17/09/2025
On 6th August 2025, Oncode conducted a focused CME session at ๐๐ผ๐๐ฝ๐ถ๐๐ฎ๐น ๐ฆ๐๐น๐๐ฎ๐ป๐ฎ๐ต ๐๐ฎ๐ต๐ถ๐๐ฎ๐ต, bringing together a group of dedicated clinical haematology staff.
The session focused on ๐ฝ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐ฎ๐ฝ๐ฝ๐ฟ๐ผ๐ฎ๐ฐ๐ต๐ฒ๐ ๐ถ๐ป ๐๐๐ง๐ฏ-๐บ๐๐๐ฎ๐๐ฒ๐ฑ ๐ฎ๐ป๐ฑ ๐ฟ๐ฒ๐น๐ฎ๐ฝ๐๐ฒ๐ฑ/๐ฟ๐ฒ๐ณ๐ฟ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐๐ฐ๐๐๐ฒ ๐ ๐๐ฒ๐น๐ผ๐ถ๐ฑ ๐๐ฒ๐๐ธ๐ฒ๐บ๐ถ๐ฎ (๐๐ ๐), given the intermediate risk posed by FLT3-ITD mutations and the available targeted FLT3 inhibitor treatment options. We also emphasised the critical importance of ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ฎ๐ ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐น ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐ถ๐ ๐ฎ๐ป๐ฑ ๐ฟ๐ฒ๐น๐ฎ๐ฝ๐๐ฒ๐ฑ/๐ฟ๐ฒ๐ณ๐ฟ๐ฎ๐ฐ๐๐ผ๐ฟ๐ ๐ฑ๐ถ๐๐ฒ๐ฎ๐๐ฒ to determine mutation status and support timely, informed treatment decisions.
Thank you to the Hospital Sultanah Bahiyah team for your continued commitment to advancing precision medicine in haematology.
15/09/2025
โจ Happy Malaysia Day! โจ
Today we celebrate not only the unity of our nation, but also the shared journey towards a stronger, healthier future.
Oncode Scientific is proud to stand with Malaysia โ advancing science, empowering healthcare, and shaping hope for generations to come. ๐
We are proud to announce a ๐น๐ฎ๐ป๐ฑ๐บ๐ฎ๐ฟ๐ธ ๐๐๐ฟ๐ฎ๐๐ฒ๐ด๐ถ๐ฐ ๐ฐ๐ผ๐น๐น๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ถ๐ผ๐ป with ๐๐ถ๐ป๐ด๐ ๐ฒ๐ฑ ๐๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ๐, Chinaโs largest independent laboratory network. This is more than a partnership; it is the convergence of two leaders to create a new force in diagnostics.
The alliance was officially sealed at a signing ceremony in ๐๐ผ๐ป๐ด ๐๐ผ๐ป๐ด on ๐ต ๐ฆ๐ฒ๐ฝ๐๐ฒ๐บ๐ฏ๐ฒ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฑ, officiated by Assoc. Prof. Dr. Su Wen Lim, ๐๐ผ๐๐ป๐ฑ๐ถ๐ป๐ด ๐๐๐ข ๐ผ๐ณ ๐ข๐ป๐ฐ๐ผ๐ฑ๐ฒ, and ๐ ๐ฎ๐ฑ๐ฎ๐บ ๐ง๐ถ๐ป๐ด ๐ฌ๐ฎ๐ป, ๐ฃ๐ฟ๐ฒ๐๐ถ๐ฑ๐ฒ๐ป๐ ๐ผ๐ณ ๐๐๐ฎ๐ป๐ด๐๐ต๐ผ๐ ๐๐ถ๐ป๐ด๐ ๐ฒ๐ฑ ๐๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ ๐๐ฟ๐ผ๐๐ฝ.
๐จ๐ป๐ถ๐๐ถ๐ป๐ด ๐ฐ๐ผ๐บ๐ฝ๐น๐ฒ๐บ๐ฒ๐ป๐๐ฎ๐ฟ๐ ๐ฒ๐ ๐ฝ๐ฒ๐ฟ๐๐ถ๐๐ฒ in innovation, AI, and diagnostics, we are creating a platform capable of tackling healthcareโs most complex challenges.
The strategic implications are vast. This alliance enables a ๐๐๐ผ-๐๐ฎ๐ ๐ฒ๐ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ ๐ผ๐ณ ๐๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ ๐ฎ๐ป๐ฑ ๐ฐ๐ฎ๐ฝ๐ฎ๐ฏ๐ถ๐น๐ถ๐๐, designed ๐๐ผ ๐ฟ๐ฒ๐ฑ๐ฒ๐ณ๐ถ๐ป๐ฒ ๐๐๐ฎ๐ป๐ฑ๐ฎ๐ฟ๐ฑ๐ and ๐ฎ๐ฐ๐ฐ๐ฒ๐น๐ฒ๐ฟ๐ฎ๐๐ฒ ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฒ๐๐ across regions.
Together, we are tackling healthcareโs most complex challenges from multiple fronts. The goal is clear: to set ๐ฎ ๐ป๐ฒ๐ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ฏ๐ฒ๐ป๐ฐ๐ต๐บ๐ฎ๐ฟ๐ธ for what diagnostic collaboration can achieve.
๐ Join Oncode at ๐ ๐๐๐๐ฃ ๐ฎ๐ฌ๐ฎ๐ฑ โ ๐ต๐๐ต ๐๐ป๐ป๐๐ฎ๐น ๐ฆ๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐ ๐ฒ๐ฒ๐๐ถ๐ป๐ด!
๐ Courtyard by Marriott, Melaka
๐ 12โ14 September 2025
Weโre honoured to join this yearโs MABIP ASM as we work together to advance pulmonology excellence through innovation and precision diagnostics.
/
Donโt miss our ๐ฌ๐ ๐ผ๐ฟ๐ป๐ถ๐ป๐ด ๐ง๐ฒ๐ฎ ๐ฆ๐๐บ๐ฝ๐ผ๐๐ถ๐๐บ happening on Day 2 of MABIP 2025!
๐ Topic: The Role of NGS in Advancing Respiratory Oncology
๐ 13 Sept | ๐ค 9:30โ10:00AM | Grand Ballroom
Explore NGS from both scientific and clinical perspectives, featuring expert insights from:
๐ฉโ๐ฌ Dr. Goh Share Yuan - Chief Scientific Officer, Oncode
๐จโโ Prof. Dr. How Soon Hin - Chest & General Physician, IIUM
/
๐ ๐ฉ๐ถ๐๐ถ๐ ๐จ๐ ๐ฎ๐ ๐๐ผ๐ผ๐๐ต ๐๐ฌ๐ฒ
Discover our advanced tissue- & liquid-based molecular solutions in lung cancer diagnostics and care.
We look forward to connecting with you!
09/09/2025
As part of our ongoing commitment to precision oncology, Oncode held an engaging CME session on 6th August 2025 at the Chest Department, Hospital Sultanah Bahiyah, with 20 clinical staff in attendance.
The session explored the ๐ฝ๐ฟ๐ฒ๐๐ฎ๐น๐ฒ๐ป๐ฐ๐ฒ ๐ผ๐ณ ๐ฎ๐ฐ๐๐ถ๐ผ๐ป๐ฎ๐ฏ๐น๐ฒ ๐ด๐ฒ๐ป๐ฒ๐๐ถ๐ฐ ๐ฎ๐น๐๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป๐ in ๐ก๐ผ๐ป-๐ฆ๐บ๐ฎ๐น๐น ๐๐ฒ๐น๐น ๐๐๐ป๐ด ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ (๐ก๐ฆ๐๐๐) ๐ถ๐ป ๐ ๐ฎ๐น๐ฎ๐๐๐ถ๐ฎ and how opting for ๐ก๐ฒ๐ ๐-๐๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ฆ๐ฒ๐พ๐๐ฒ๐ป๐ฐ๐ถ๐ป๐ด (๐ก๐๐ฆ) empowers clinicians to make more accurate and personalised treatment decisions. It also highlighted Oncodeโs testing capabilities, reaffirming our role in delivering ๐ฟ๐ฒ๐น๐ถ๐ฎ๐ฏ๐น๐ฒ ๐ฎ๐ป๐ฑ ๐ฐ๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ๐ to support cancer care.
We thank the Hospital Sultanah Bahiyah chest team for their valuable time and dedication to advancing personalised lung cancer care.
๐ At ๐๐ง๐๐จ๐๐, every test we perform brings hope โ helping patients and doctors get the right answers at the right time. Join us in building Malaysiaโs future in precision cancer diagnostics.
Join us if you want your skills to ๐ฆ๐๐ค๐ ๐ ๐ซ๐๐๐ฅ ๐๐ข๐๐๐๐ซ๐๐ง๐๐ in peopleโs lives.
๐ฌ ๐. ๐๐๐๐ข๐๐๐ฅ ๐๐๐๐จ๐ซ๐๐ญ๐จ๐ซ๐ฒ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ฌ๐ญ (๐๐ข๐ฌ๐ญ๐จ๐ฉ๐๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ฒ)
Bring histological insight to cancer diagnostics.
โ๏ธ Diploma/Degree in MLT, Biomedical Science or relevant fields
โ๏ธ Skilled in histopathology techniques (tissue processing, embedding, microtomy, H&E staining)
โ๏ธ Familiar with lab QA/QC and MOH APC preferred
โ๏ธ Meticulous, reliable & a strong team player
๐งช ๐. ๐&๐ ๐๐๐ข๐๐ง๐ญ๐ข๐ฌ๐ญ
Drive innovation in assay development & molecular diagnostics with impact.
โ๏ธ Masterโs/PhD in Molecular Biology, Biotech, or Biomedical Science
โ๏ธ Hands-on experience in molecular techniques and laboratory sciences
โ๏ธ A curious problem-solver passionate about science
๐ฅ๏ธ ๐. ๐๐ข๐จ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐๐ข๐๐ง
Turn complex genomic data into actionable clinical insights.
โ๏ธ Degree or higher in Bioinformatics / Computational Biology / Computer Science (with bio focus)
โ๏ธ Proficiency in NGS data analysis, pipeline development, and statistical tools
โ๏ธ Experience with Python/R, Linux, and databases preferred
โ๏ธ Strong analytical thinker with attention to detail
โ๏ธ Fresh graduates with
๐ ๐. ๐๐ฎ๐ฌ๐ข๐ง๐๐ฌ๐ฌ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ ๐๐ฑ๐๐๐ฎ๐ญ๐ข๐ฏ๐
Bring life-saving diagnostics from the lab to the clinic.
โ๏ธ Degree in Science, Biotech, or Business
โ๏ธ Passion for healthcare & partnerships
โ๏ธ Fresh graduates are encouraged to apply!
๐ ๐. ๐๐๐๐จ๐ฎ๐ง๐ญ๐ฌ ๐๐ฑ๐๐๐ฎ๐ญ๐ข๐ฏ๐
Turn numbers into impact for better patient care.
โ๏ธ Diploma/Degree in Accounting or Finance
โ๏ธ Detail-oriented & responsible
โ๏ธ Strong in Excel & accounting software
โ๏ธ Fresh graduates are welcome!
๐ ๐๐จ๐๐๐ญ๐ข๐จ๐ง: Shah Alam, Selangor
๐ผ ๐๐ฆ๐ฉ๐ฅ๐จ๐ฒ๐ฆ๐๐ง๐ญ ๐๐ฒ๐ฉ๐: Full-Time | Immediate Hiring
๐ฒ๐พ ๐๐๐ฅ๐๐ฒ๐ฌ๐ข๐๐ง ๐๐๐ง๐๐ข๐๐๐ญ๐๐ฌ ๐๐ซ๐ ๐๐ง๐๐จ๐ฎ๐ซ๐๐ ๐๐ ๐ญ๐จ ๐๐ฉ๐ฉ๐ฅ๐ฒ!
๐ก ๐๐ก๐ฒ ๐๐จ๐ข๐ง ๐๐ง๐๐จ๐๐?
๐ ๐๐ฎ๐ซ๐ฉ๐จ๐ฌ๐ ๐ฐ๐ข๐ญ๐ก ๐๐ฆ๐ฉ๐๐๐ญ โ Every role contributes directly to improving cancer diagnostics and transforming patient care.
๐ ๐๐ซ๐จ๐ฐ๐ญ๐ก & ๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ๐ฒ โ Work at the forefront of molecular science, AI, and healthcare innovation โ a place where curiosity is celebrated.
๐ค ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐ฏ๐ ๐๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐ โ Join a passionate, supportive team that thrives on shared goals and meaningful results.
๐ ๐๐๐ฎ๐ง๐๐ก๐ฉ๐๐ ๐๐จ๐ซ ๐๐๐ฅ๐๐ง๐ญ โ Perfect for fresh graduates and early-career professionals eager to grow in a science-driven environment.
๐ ๐๐๐ญ๐ข๐จ๐ง๐๐ฅ & ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฑ๐ฉ๐จ๐ฌ๐ฎ๐ซ๐ โ Be part of a Malaysian company making waves regionally and globally in precision medicine.
๐๐๐๐๐ฒ ๐ญ๐จ ๐ฉ๐ฎ๐ญ ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐ค๐ข๐ฅ๐ฅ๐ฌ ๐ญ๐จ ๐ฆ๐๐๐ง๐ข๐ง๐ ๐๐ฎ๐ฅ ๐ฎ๐ฌ๐?
โจ Scan the ๐๐ ๐๐จ๐๐ in the photo to apply instantly!
๐ฉ Or email your CV to: recruit@oncodesc.com
๐ฑ Letโs grow together. Join us at Oncode.
30/08/2025
๐ฒ๐พ ๐๐๐ฅ๐ฅ๐ฎ ๐๐๐ง๐๐๐ ๐, ๐๐๐ก๐๐ฎ๐จ๐๐! As we celebrate 68 years of independence, Oncode Scientific remains committed to driving innovation in science and healthcare โ empowering better treatments, better outcomes, and a healthier future for all Malaysians. ๐โจ
19/08/2025
On 7th August 2025, Oncode held a CME session with the ๐๐ฒ๐ฝ๐ฎ๐ฟ๐๐บ๐ฒ๐ป๐ ๐ผ๐ณ ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐ฎ๐ ๐จ๐ป๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐ ๐ ๐ฎ๐น๐ฎ๐๐ฎ ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐ป๐๐ฟ๐ฒ (๐จ๐ ๐ ๐), centered on โ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ ๐จ๐ ๐๐๐ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐ข๐ง ๐๐๐ซ๐ฌ๐จ๐ง๐๐ฅ๐ข๐ณ๐๐ ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐.โ
We showcased how ๐ข๐ป๐ฐ๐ผ๐ฑ๐ฒ ๐๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ผ๐ฟ๐โ๐ ๐ฎ๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ฑ ๐ฑ๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ๐ empower precision oncology, with highlights on the ๐ฃ๐ข๐ฆ๐ฆ๐๐๐๐ ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ ๐ณ๐ผ๐ฟ ๐น๐๐ป๐ด ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ, ๐๐ฅ๐ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐ผ๐๐ฎ๐ฟ๐ถ๐ฎ๐ป ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ, ๐ฎ๐ป๐ฑ ๐น๐ถ๐พ๐๐ถ๐ฑ/๐๐ถ๐๐๐๐ฒ ๐ฏ๐ถ๐ผ๐ฝ๐๐ ๐ฎ๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ across multiple cancer types.
The session also emphasised the ๐๐๐ฝ๐ฒ๐ฟ๐ถ๐ผ๐ฟ ๐๐ฒ๐ป๐๐ถ๐๐ถ๐๐ถ๐๐ ๐ฎ๐ป๐ฑ ๐ฏ๐ฟ๐ผ๐ฎ๐ฑ๐ฒ๐ฟ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป ๐ฐ๐ผ๐๐ฒ๐ฟ๐ฎ๐ด๐ฒ of NGS compared to PCR, reinforcing its value in guiding ๐๐ฎ๐ถ๐น๐ผ๐ฟ๐ฒ๐ฑ ๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐๐๐ฟ๐ฎ๐๐ฒ๐ด๐ถ๐ฒ๐. Real-world ๐ฐ๐ฎ๐๐ฒ ๐๐๐๐ฑ๐ถ๐ฒ๐ demonstrated how NGS testing directly informed and optimised treatment planning.
Thank you to the UMMC oncology team for the meaningful exchange in driving forward personalised cancer care.
08/08/2025
On 15th July 2025, Oncode conducted a CME session with the ๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐ ๐๐ฒ๐ฎ๐บ ๐ฎ๐ ๐๐ต๐ฒ ๐ก๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐ป๐๐๐ถ๐๐๐๐ฒ (๐๐๐ก), focusing on advancements in ๐ด๐ฒ๐ป๐ผ๐บ๐ถ๐ฐ ๐๐ฒ๐๐๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐ผ๐๐ฎ๐ฟ๐ถ๐ฎ๐ป ๐ฎ๐ป๐ฑ ๐ป๐ฎ๐๐ผ๐ฝ๐ต๐ฎ๐ฟ๐๐ป๐ด๐ฒ๐ฎ๐น ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ๐.
The session introduced ๐ข๐ป๐ฐ๐ผ๐ฑ๐ฒโ๐ ๐๐ฅ๐ ๐ฝ๐ฎ๐ป๐ฒ๐น, emphasising the value of ๐๐ฅ๐ ๐๐ฐ๐ฟ๐ฒ๐ฒ๐ป๐ถ๐ป๐ด ๐ฏ๐ฒ๐๐ผ๐ป๐ฑ ๐๐ฅ๐๐๐ญ/๐ฎ ๐บ๐๐๐ฎ๐๐ถ๐ผ๐ป๐. Identifying HRD-positive cases enables access to ๐ต๐ถ๐ด๐ต๐น๐ ๐ฒ๐ณ๐ณ๐ฒ๐ฐ๐๐ถ๐๐ฒ ๐๐ฎ๐ฟ๐ด๐ฒ๐๐ฒ๐ฑ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ถ๐ฒ๐, expanding treatment options for ovarian cancer patients.
We also presented our latest ๐ผ๐๐๐๐ผ๐๐ฟ๐ฐ๐ฒ๐ฑ ๐๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐ก๐ฎ๐๐ผ๐ฝ๐ต๐ฎ๐ฟ๐๐ป๐ด๐ฒ๐ฎ๐น ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ (๐ก๐ฃ๐), featuring panels designed for ๐๐ฐ๐ฟ๐ฒ๐ฒ๐ป๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐ฝ๐ผ๐๐-๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐บ๐ผ๐ป๐ถ๐๐ผ๐ฟ๐ถ๐ป๐ดโproviding critical insights on recurrence risk following radio/chemotherapy.
Thank you to the IKN team for your continued dedication to precision oncology.
06/08/2025
๐ข MTDC x Oncode: A Bold Step Forward for Malaysiaโs Healthcare Innovation
Be the first to know and let us send you an email when Oncode Scientific Sdn Bhd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
ONCODE Scientific Sdn Bhd was founded in 2015, by a strong knowledge-based management and operational team with the combination of more than 85 years of experience in the areas of medical diagnostics and scientific research. Itโs aims to be a niche player specializing in Precision Medicine utilizing the techniques of Next Generation Sequencing (NGS), Sanger sequencing, Real-Time & Standard PCR technologies. The team comprises of scientists, geneticists, physicians, pharmacists, bioinformaticians and business veterans who aim to deliver the best quality and affordable molecular diagnostic solutions to the global community.
Oncode laboratory workflows and pipelines include internal and external validation quality controls for compliance with international standards of Good Laboratory Practice (GLP), ISO 15189, the Association for Molecular Pathology (AMP) and the College of American Pathologist (CAP).
The laboratory participates in external quality assurance and proficiency programs including the UK National External Quality Assurance System (UKNEQAS), The European Molecular Genetics Quality Network (EMQN) and the Royal College of Pathologists of Australasia (RCPA).
Oncode Mission
To provide quality diagnostic solutions to customers through the implementation of state-of-the-art laboratory setup designed to worldwide standards, recruitment of dedicated professionals and comprehensive reporting systems.
Oncode Objective
To be a regional one-stop molecular genetics solution center, delivering powerful diagnostic support and insight to medical professionals
